These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27713154)

  • 41. Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression.
    Chen B; Zhang Y; Wang Y; Rao J; Jiang X; Xu Z
    J Steroid Biochem Mol Biol; 2014 Sep; 143():11-8. PubMed ID: 24486718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
    Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastrin stimulates pancreatic cancer cell directional migration by activating the Gα12/13-RhoA-ROCK signaling pathway.
    Mu G; Ding Q; Li H; Zhang L; Zhang L; He K; Wu L; Deng Y; Yang D; Wu L; Xu M; Zhou J; Yu H
    Exp Mol Med; 2018 May; 50(5):1-14. PubMed ID: 29717112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway.
    Cheng CI; Chen PH; Lin YC; Kao YH
    Cell Signal; 2015 Feb; 27(2):283-92. PubMed ID: 25446262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
    Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
    Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophage nuclear factor erythroid 2-related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3-mediated RhoA/ROCK pathway in the ischemic liver.
    Rao J; Qiu J; Ni M; Wang H; Wang P; Zhang L; Wang Z; Liu M; Cheng F; Wang X; Lu L
    Hepatology; 2022 Jun; 75(6):1429-1445. PubMed ID: 34624146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.
    Hauser AD; Bergom C; Schuld NJ; Chen X; Lorimer EL; Huang J; Mackinnon AC; Williams CL
    Mol Cancer Res; 2014 Jan; 12(1):130-42. PubMed ID: 24197117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway.
    Tang X; Jin R; Qu G; Wang X; Li Z; Yuan Z; Zhao C; Siwko S; Shi T; Wang P; Xiao J; Liu M; Luo J
    Cancer Res; 2013 Oct; 73(20):6206-18. PubMed ID: 24008316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion.
    Kwon A; Lee HL; Woo KM; Ryoo HM; Baek JH
    Mol Cells; 2013 Dec; 36(6):548-55. PubMed ID: 24241683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.
    Hirsch DS; Shen Y; Wu WJ
    Cancer Res; 2006 Apr; 66(7):3523-30. PubMed ID: 16585176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
    Han L; Liu B; Jiang L; Liu J; Han S
    Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyr42 phosphorylation of RhoA GTPase promotes tumorigenesis through nuclear factor (NF)-κB.
    Kim JG; Choi KC; Hong CW; Park HS; Choi EK; Kim YS; Park JB
    Free Radic Biol Med; 2017 Nov; 112():69-83. PubMed ID: 28712859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. H-Ras induces Nrf2-Pin1 interaction: Implications for breast cancer progression.
    Saeidi S; Kim SJ; Han HJ; Kim SH; Zheng J; Lee HB; Han W; Noh DY; Na HK; Surh YJ
    Toxicol Appl Pharmacol; 2020 Sep; 402():115121. PubMed ID: 32621833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue factor mediates microvesicles shedding from MDA-MB-231 breast cancer cells.
    Rondon AMR; de Almeida VH; Gomes T; Verçoza BRF; Carvalho RS; König S; Rodrigues JCF; Mermelstein CDS; Versteeg HH; Monteiro RQ
    Biochem Biophys Res Commun; 2018 Jul; 502(1):137-144. PubMed ID: 29787758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NRF2 transcriptionally activates the
    Paul S; Ghosh S; Mandal S; Sau S; Pal M
    J Biol Chem; 2018 Dec; 293(50):19303-19316. PubMed ID: 30309986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of miR-101 on proliferation and oxidative stress-induced apoptosis of breast cancer cells via Nrf2 signaling pathway.
    Yi J; Huang WZ; Wen YQ; Yi YC
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8931-8939. PubMed ID: 31696480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling.
    Kalpana G; Figy C; Yeung M; Yeung KC
    Sci Rep; 2019 Nov; 9(1):16351. PubMed ID: 31705019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.
    Zhu W; Ma L; Yang B; Zheng Z; Chai R; Liu T; Liu Z; Song T; Li F; Li G
    In Vitro Cell Dev Biol Anim; 2016 May; 52(5):589-97. PubMed ID: 26935193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.